Gaush Meditech Statistics

Total Valuation

Gaush Meditech has a market cap or net worth of EUR 105.09 million. The enterprise value is 110.45 million.

Market Cap	105.09M
Enterprise Value	110.45M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	Jun 23, 2025

Share Statistics

Current Share Class	146.67M
Shares Outstanding	n/a
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	51.41M

Valuation Ratios

The trailing PE ratio is 8.60.

PE Ratio	8.60
Forward PE	n/a
PS Ratio	0.56
PB Ratio	0.50
P/TBV Ratio	2.15
P/FCF Ratio	8.53
P/OCF Ratio	7.37
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.88, with an EV/FCF ratio of 8.96.

EV / Earnings	9.03
EV / Sales	0.67
EV / EBITDA	3.88
EV / EBIT	5.77
EV / FCF	8.96

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.35.

Current Ratio	2.25
Quick Ratio	1.34
Debt / Equity	0.35
Debt / EBITDA	2.24
Debt / FCF	5.93
Interest Coverage	4.51

Financial Efficiency

Return on equity (ROE) is 5.39% and return on invested capital (ROIC) is 4.60%.

Return on Equity (ROE)	5.39%
Return on Assets (ROA)	3.83%
Return on Invested Capital (ROIC)	4.60%
Return on Capital Employed (ROCE)	8.06%
Revenue Per Employee	213,826
Profits Per Employee	13,831
Employee Count	884
Asset Turnover	0.53
Inventory Turnover	2.34

Taxes

In the past 12 months, Gaush Meditech has paid 8.83 million in taxes.

Income Tax	8.83M
Effective Tax Rate	42.99%

Stock Price Statistics

The stock price has decreased by -49.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-49.30%
50-Day Moving Average	0.67
200-Day Moving Average	0.96
Relative Strength Index (RSI)	52.35
Average Volume (20 Days)	697

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gaush Meditech had revenue of EUR 189.02 million and earned 12.23 million in profits. Earnings per share was 0.08.

Revenue	189.02M
Gross Profit	86.54M
Operating Income	21.91M
Pretax Income	20.55M
Net Income	12.23M
EBITDA	29.47M
EBIT	21.91M
Earnings Per Share (EPS)	0.08

Full Income Statement

Balance Sheet

The company has 68.68 million in cash and 73.08 million in debt, giving a net cash position of -4.40 million.

Cash & Cash Equivalents	68.68M
Total Debt	73.08M
Net Cash	-4.40M
Net Cash Per Share	n/a
Equity (Book Value)	210.17M
Book Value Per Share	1.42
Working Capital	84.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.26 million and capital expenditures -1.94 million, giving a free cash flow of 12.32 million.

Operating Cash Flow	14.26M
Capital Expenditures	-1.94M
Free Cash Flow	12.32M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 45.78%, with operating and profit margins of 11.59% and 6.47%.

Gross Margin	45.78%
Operating Margin	11.59%
Pretax Margin	10.87%
Profit Margin	6.47%
EBITDA Margin	15.59%
EBIT Margin	11.59%
FCF Margin	6.52%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 4.57%.

Dividend Per Share	0.03
Dividend Yield	4.57%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	160.78%
Buyback Yield	0.14%
Shareholder Yield	4.71%
Earnings Yield	11.63%
FCF Yield	11.73%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gaush Meditech has an Altman Z-Score of 3.34 and a Piotroski F-Score of 6.

Altman Z-Score	3.34
Piotroski F-Score	6